- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04020549
Single-Session Computerized Mental Health Intervention for Rural Indian Adolescents
Evaluating the Effectiveness of a Computerized, School-Based, Single-Session Intervention for Rural Indian Adolescents
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maharashtra
-
Pune, Maharashtra, India
- Z P school, Wablewadi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Attending a participating secondary school
- Age 12 to 18
- Literate in English
Exclusion Criteria:
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
|
Reading and writing activities based on growth (designed to instill the belief that people can change), gratitude (noticing and appreciating good things in life), and behavioral activation (identifying and scheduling positive activities).
|
Sham Comparator: Study Skills Control
|
Reading and writing activities designed to teach evidence-based study strategies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in The Warwick-Edinburgh Mental Wellbeing Scale
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Well-being questionnaire.
Total score ranges from 14 to 70.
Higher values indicate a better outcome.
|
Baseline, 4 week follow-up, 12 week follow-up
|
Intervention Appropriateness Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
|
Questionnaire measuring the appropriateness of an intervention.
Appropriateness refers to the perceived fit or relevance of an intervention.
The total score ranges from 4 to 20.
Higher scores indicate a better outcome.
|
Immediately post-intervention (i.e., 0 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire-9
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Depression Questionnaire.
The total score ranges from 0 to 27.
Lower scores indicate a better outcome.
|
Baseline, 4 week follow-up, 12 week follow-up
|
Generalized Anxiety Disorder Screener-7
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. |
Baseline, 4 week follow-up, 12 week follow-up
|
The EPOCH Measure of Adolescent Well-being
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Questionnaire with five subscales measuring engagement, perseverance, optimism, connectedness, and happiness.
Each subscale score ranges from 4 to 20.
Higher scores indicate a better outcome.
The happiness and optimism subscales will be used as secondary outcomes for this trial.
A total score is not computed.
|
Baseline, 4 week follow-up, 12 week follow-up
|
Acceptability of Intervention Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
|
Questionnaire measuring the acceptability of an intervention.
Acceptability refers to the perception that a given treatment is agreeable or satisfactory.
The total score ranges from 4 to 20.
Higher scores indicate a better outcome.
|
Immediately post-intervention (i.e., 0 weeks)
|
Feasibility of Intervention Measure
Time Frame: Immediately post-intervention (i.e., 0 weeks)
|
Questionnaire measuring the feasibility of an intervention.
Feasibility refers to the degree to which a treatment can be successfully implemented in a given setting.
The total score ranges from 4 to 20.
Higher scores indicate a better outcome.
|
Immediately post-intervention (i.e., 0 weeks)
|
Perceived Stress Scale-4
Time Frame: Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Questionnaire measuring perceived stress.
The total score ranges from 0 to 16. Lower scores indicate a better outcome.
|
Time Frame: Baseline, 4 week follow-up, 12 week follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Rob DeRubeis, PhD, University of Pennsylvania
- Study Director: Sachin Shinde, PhD, Sangath
- Study Director: Sadhana Natu, PhD, Modern College Pune
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 30927492
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Growth, Gratitude, & Positive Activities
-
University of SheffieldThe Leeds Teaching Hospitals NHS Trust; Sheffield Teaching Hospitals NHS Foundation... and other collaboratorsCompletedDepression | Wellbeing | Psychological Distress | Happiness | Emotional Distress | AffectUnited Kingdom
-
University of MichiganCompletedBreast CancerUnited States
-
University of PennsylvaniaSangathCompletedDepression | Anxiety | Well-beingIndia
-
VA Office of Research and DevelopmentCompleted
-
Universitat Jaume IHospital Provincial de Castellon; PREVI Clinical CenterCompletedEating Disorder | Daily ActivitiesSpain
-
University of California, San FranciscoCompleted
-
Universitat Jaume ICompleted
-
University of Michigan Rogel Cancer CenterDepartment of Health and Human ServicesRecruitingHematologic DiseasesUnited States
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownHepatocellular CarcinomaJapan
-
Centre Hospitalier Universitaire, AmiensInstitut Bergonié; Centre Henri Becquerel; Saint-Louis Hospital, Paris, France; Henri Mondor University Hospital and other collaboratorsRecruitingChemotherapy | Elderly | Diffuse Large B-Cell Lymphoma (DLBCL), NosFrance